New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?-Reference-Cited by-同舟云学术

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Published:2015-07-22 Issue:28 Volume:6 Page:24780-24796
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bronte Giuseppe¹,Silvestris Nicola²,Castiglia Marta¹,Galvano Antonio¹,Passiglia Francesco¹,Sortino Giovanni¹,Cicero Giuseppe¹,Rolfo Christian³,Peeters Marc³,Bazan Viviana¹,Fanale Daniele¹,Giordano Antonio⁴⁵,Russo Antonio¹

Affiliation:

1. Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy

2. Medical Oncology Unit, National Cancer Institute “Giovanni Paolo II”, Bari, Italy

3. Department of Oncology, University Hospital of Antwerp, Edegem, Belgium

4. Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, USA

5. Department of Medicine, Surgery & Neuroscience, University of Siena, Siena, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients;Journal of Gastrointestinal Cancer;2024-05-06

2. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance;Cell Biochemistry and Function;2024-01

3. A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer;Cancer Research and Treatment;2023-12-07

4. Translational research of new developments in targeted therapy of colorectal cancer;Pathology - Research and Practice;2023-12

5. Embarazo en neoplasias mieloproliferativas;Gaceta Médica de México;2023-09-20